Company Monitoring Page for Merck

latest headlines for company on cafepharma

Setting the Stage for ASH 2022
BioSpace
Fri, 12/9/22 - 10:50 am
Tags:
ASH 2022, AstraZeneca, Janssen, Merck, Vega Therapeutics
Mirati to focus adagrasib/Keytruda study in low PDL1 lung cancer patients
Yahoo/Reuters
Tue, 12/6/22 - 10:21 am
Tags:
Mirati Therapeutics, adagrasib, Merck, Keytruda, metastatic lung cancer, lung cancer
GSK unveils Keytruda head-to-head data in lung cancer—and they look good at first glance
Fierce Pharma
Wed, 11/30/22 - 07:58 pm
Tags:
GSK, Merck, Jemperli, Keytruda, clinical trials, non-small cell lung cancer
Merck to Leverage BigHat's AI Platform in 3 Drug Discovery Programs
BioSpace
Tue, 11/29/22 - 08:25 pm
Tags:
Merck, BigHat Biosciences, R&D, artificial intelligence
Merck scores another win for Keytruda, this time in HER2-negative cancer
Endpoints
Tue, 11/22/22 - 04:39 pm
Tags:
Merck, Keytruda, clinical trials, adenocarcinoma
Merck & Co. inks $1.4B blood cancer biotech buyout to muscle in on Bristol Myers, Novartis
Fierce Biotech
Mon, 11/21/22 - 10:33 am
Tags:
Merck, M&A, Imago BioSciences, blood cancer
Gossamer could put pressure on Merck
EP Vantage
Fri, 11/11/22 - 10:26 am
Tags:
Merck, Gossamer Bio, PAH, sotatercept, United Therapeutics, ralinepag
Sotatercept- the breakthrough PAH has been waiting for?
Clinical Trials Arena
Thu, 11/10/22 - 10:31 am
Tags:
Merck, sotatercept, Acceleron, PAH
Is Merck Too Dependent on Keytruda?
Motley Fool
Wed, 11/9/22 - 10:50 am
Tags:
Merck, Keytruda
Catching up with Keytruda, Regeneron scores frontline NSCLC approval for Libtayo/chemo combo
Endpoints
Wed, 11/9/22 - 10:38 am
Tags:
Regeneron, Libtayo, non-small cell lung cancer, Keytruda, Merck
Gilead, Arcus slim phase 3 TIGIT trial to take on king Keytruda
Fierce Biotech
Thu, 11/3/22 - 11:10 am
Tags:
Gilead Sciences, ARCUS, clinical trials, Merck, Keytruda, domvanalimab, zimberelimab, non-small cell lung cancer
A timeline of Ken Frazier’s tenure at Merck
Medical Marketing and Media
Sun, 10/30/22 - 04:13 pm
Tags:
Kenneth Frazier, Merck, Pharma CEOs
Merck CEO Rob Davis has business development on the brain as he builds 'pipeline of the future'
Endpoints
Fri, 10/28/22 - 10:22 am
Tags:
Merck, Rob Davis, Pharma CEOs, M&A
Kenneth Frazier announces retirement after decades at Merck
Medical Marketing and Media
Thu, 10/27/22 - 08:26 pm
Tags:
Merck, Kenneth Frazier, Pharma CEOs
Merck Stock Jumps As Keytruda Sales Power Q3 Earnings Beat, Profit Forecast Boost
TheStreet.com
Thu, 10/27/22 - 10:46 am
Tags:
Merck, earnings
MS Drug Advances from Merck, BMS and More Showcased at ECTRIMS Conference
BioSpace
Wed, 10/26/22 - 06:51 pm
Tags:
Merck, Biogen, Bristol Myers Squibb, MS, multiple sclerosis, ECTRIMS
Is Merck Moving Toward Another Blockbuster Drug Launch?
Motley Fool
Wed, 10/26/22 - 10:32 am
Tags:
Merck, sotatercept, PAH
Merck fined $38M in Spain for hindering generic competition for NuvaRing
Fierce Pharma
Tue, 10/25/22 - 11:07 pm
Tags:
Merck, Spain, anti-competitive scheme
Merck tees up Prevymis filing in kidney transplant recipients after phase 3 trial win
Fierce Pharma
Mon, 10/24/22 - 10:56 am
Tags:
Merck, Prevymis, kidney transplants, clinical trials, CMV, IDWeek
Bristol Myers spells out Opdivo win in melanoma — how does it stack up against Keytruda?
Endpoints
Thu, 10/20/22 - 10:41 am
Tags:
Bristol Myers Squibb, Opdivo, melanoma, Merck, Keytruda

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.